Ethiopia’s pharmaceutical regulation reached a milestone in 2026. The country became the first in the IGAD region and the ninth in Africa to achieve World Health Organization Maturity Level 3 for its medicines regulatory system, and local production now covers more than 40% of the medicine supply (World Bank, May 2026). For importers and buyers, stricter regulation means a clearer, more predictable rulebook. This guide lays out the import rules as they stand in 2026.
Treat this as an orientation, not legal advice. The Ethiopian Food and Drug Authority (EFDA) updates its directives, and controlled substances, donations, and emergency imports carry their own rules. Confirm the current detail with EFDA or an established importer before you commit capital.
The 2026 regulatory landscape
EFDA regulates medicines and medical devices end to end, from registration through import to distribution. The legal backbone is the Food and Medicine Administration Proclamation No. 1112/2019, supported by newer instruments including Council of Ministers Regulation No. 531/2023 and the Medicine Marketing Authorization Directive No. 963/2023, which gives EFDA authority for expedited processing of certain applications (EFDA Guideline for Registration of Medicine, 2024). The WHO Maturity Level 3 rating signals that this system now meets international benchmarks for a functional regulator.
Rule 1: Register the product before you import it
A licence lets you import; registration lets you import a specific product. Every medicine must be registered with EFDA before it enters the country. Applications go through EFDA’s online eRIS portal, where you assign a technical focal person to manage the dossier. EFDA evaluates applications chronologically on a first-in-first-out basis, and a registration stays valid for five years before re-registration (EFDA, 2024). Products an established importer has already registered are a genuine shortcut, which is why buyers often source registered lines rather than starting from zero. Our full walkthrough sits in how to import medicine into Ethiopia.
Rule 2: Medical devices follow a risk-based path
Medical devices need EFDA marketing authorization before they reach the market, under Article 20(1) of Proclamation 1112/2019. EFDA sorts devices by risk: non-IVD devices fall into Class I to IV, with Class I the lowest risk and Class IV the highest, while in-vitro diagnostic devices run Class A to D, with Class A the lowest and Class D the highest (EFDA Medical Devices Guideline). Higher risk means more rigorous assessment. Applications run through eRIS in two stages, screening then evaluation, with published service fees set by Council of Ministers regulation. If you import equipment, read our medical equipment buyer’s guide next.
Rule 3: Each consignment needs a cleared path
Registration is not the end. To bring a consignment in, EFDA’s process requires a competence certificate, an Authority-approved purchase order for the products, and a port-clearance permit to release the goods at the point of entry. Distribution is then restricted to authorised institutions according to their level (EFDA import requirements). At the port, EFDA checks that the consignment matches the approval, the packaging is intact, batch numbers and expiry dates are valid, and the cold chain held for temperature-sensitive items.
Rule 4: Storage and distribution stay regulated
Once cleared, products must be stored and moved under Good Distribution Practice: temperature control, batch traceability, and proper handling to the end user. The regulatory duty follows the product all the way to delivery, not just to the port. For temperature-sensitive medicines, the cold chain is the part that most often goes wrong. Our guide on the pharmaceutical cold chain in Ethiopia covers what buyers should demand.
What this means for importers and buyers
The 2026 picture is a tighter system that punishes shortcuts and rewards preparation. Foreign-currency access remains a real constraint on imports, which adds weight to working with suppliers who hold registered stock locally. For most hospitals, clinics, and programmes, sourcing through an importer who already meets these rules turns a months-long compliance project into a purchase order. LifeCare imports and distributes across Ethiopia under these rules. Contact the team or browse the pharmaceuticals range.
Frequently asked questions
What are the main rules for importing pharmaceuticals into Ethiopia in 2026?
Register the product with EFDA via eRIS, hold a competence certificate, get an EFDA-approved purchase order and a port-clearance permit for each consignment, and store and distribute under Good Distribution Practice. Medical devices need separate marketing authorization based on risk class.
How long is an EFDA medicine registration valid?
An EFDA medicine registration is valid for five years, after which the holder must apply for re-registration. Applications are submitted through the eRIS portal and evaluated on a first-in-first-out basis.
How are medical devices classified in Ethiopia?
EFDA classifies non-IVD medical devices as Class I to IV (lowest to highest risk) and in-vitro diagnostic devices as Class A to D (lowest to highest risk). Higher-risk classes face more rigorous conformity assessment before marketing authorization.
